111 related articles for article (PubMed ID: 10340388)
1. Restriction landmark genome scanning for aberrant methylation in primary refractory and relapsed acute myeloid leukemia; involvement of the WIT-1 gene.
Plass C; Yu F; Yu L; Strout MP; El-Rifai W; Elonen E; Knuutila S; Marcucci G; Young DC; Held WA; Bloomfield CD; Caligiuri MA
Oncogene; 1999 May; 18(20):3159-65. PubMed ID: 10340388
[TBL] [Abstract][Full Text] [Related]
2. Restriction landmark genomic scanning (RLGS-M)-based genome-wide scanning of mouse liver tumors for alterations in DNA methylation status.
Akama TO; Okazaki Y; Ito M; Okuizumi H; Konno H; Muramatsu M; Plass C; Held WA; Hayashizaki Y
Cancer Res; 1997 Aug; 57(15):3294-9. PubMed ID: 9242463
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia.
Ekmekci CG; Gutiérrez MI; Siraj AK; Ozbek U; Bhatia K
Am J Hematol; 2004 Nov; 77(3):233-40. PubMed ID: 15495254
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.
Gebhard C; Schwarzfischer L; Pham TH; Schilling E; Klug M; Andreesen R; Rehli M
Cancer Res; 2006 Jun; 66(12):6118-28. PubMed ID: 16778185
[TBL] [Abstract][Full Text] [Related]
6. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia.
Melki JR; Vincent PC; Clark SJ
Cancer Res; 1999 Aug; 59(15):3730-40. PubMed ID: 10446989
[TBL] [Abstract][Full Text] [Related]
7. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
8. [Id4 gene methylation for detection of minimal residual disease in acute leukemia].
Zhao Y; Yu L; Wang QS; Li HH; Bo J; Wang SH; Jin HJ; Lou FD
Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):298-301. PubMed ID: 16875575
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
10. HOXA5 is targeted by cell-type-specific CpG island methylation in normal cells and during the development of acute myeloid leukaemia.
Strathdee G; Sim A; Soutar R; Holyoake TL; Brown R
Carcinogenesis; 2007 Feb; 28(2):299-309. PubMed ID: 16861263
[TBL] [Abstract][Full Text] [Related]
11. Aberrant hypomethylation of the cancer-testis antigen PRAME correlates with PRAME expression in acute myeloid leukemia.
Ortmann CA; Eisele L; Nückel H; Klein-Hitpass L; Führer A; Dührsen U; Zeschnigk M
Ann Hematol; 2008 Oct; 87(10):809-18. PubMed ID: 18587578
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia.
Li Q; Kopecky KJ; Mohan A; Willman CL; Appelbaum FR; Weick JK; Issa JP
Clin Cancer Res; 1999 May; 5(5):1077-84. PubMed ID: 10353741
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia.
Galm O; Wilop S; Lüders C; Jost E; Gehbauer G; Herman JG; Osieka R
Ann Hematol; 2005 Dec; 84 Suppl 1():39-46. PubMed ID: 16231140
[TBL] [Abstract][Full Text] [Related]
14. p15 mRNA expression detected by real-time quantitative reverse transcriptase-polymerase chain reaction correlates with the methylation density of the gene in adult acute leukemia.
Matsuno N; Hoshino K; Nanri T; Kawakita T; Suzushima H; Kawano F; Mitsuya H; Asou N
Leuk Res; 2005 May; 29(5):557-64. PubMed ID: 15755508
[TBL] [Abstract][Full Text] [Related]
15. Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
Suzuki R; Onizuka M; Kojima M; Shimada M; Fukagawa S; Tsuboi K; Kobayashi H; Shintani A; Ogawa Y; Kawada H; Hotta T; Ando K
Br J Haematol; 2007 Sep; 138(5):624-31. PubMed ID: 17686056
[TBL] [Abstract][Full Text] [Related]
16. A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels.
Smiraglia DJ; Frühwald MC; Costello JF; McCormick SP; Dai Z; Peltomäki P; O'Dorisio MS; Cavenee WK; Plass C
Genomics; 1999 Jun; 58(3):254-62. PubMed ID: 10373323
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic inactivation of INK4/CDK/RB cell cycle pathway in acute leukemias.
Chim CS; Wong AS; Kwong YL
Ann Hematol; 2003 Dec; 82(12):738-42. PubMed ID: 14513284
[TBL] [Abstract][Full Text] [Related]
18. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
[TBL] [Abstract][Full Text] [Related]
19. Routine expression profiling of microarray gene signatures in acute leukaemia by real-time PCR of human bone marrow.
Sakhinia E; Faranghpour M; Liu Yin JA; Brady G; Hoyland JA; Byers RJ
Br J Haematol; 2005 Jul; 130(2):233-48. PubMed ID: 16029452
[TBL] [Abstract][Full Text] [Related]
20. The study of aberrant methylation in cancer via restriction landmark genomic scanning.
Smiraglia DJ; Plass C
Oncogene; 2002 Aug; 21(35):5414-26. PubMed ID: 12154404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
